Sign in
4

Changes in Ownership

Alto Neuroscience, Inc. Filed Acc 0001415889-24-002938

Director acquired 715,653 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Cox Christopher Nixon Director 2024-02-06 Conversion +588,898 588,898 I
Cox Christopher Nixon Director 2024-02-06 Conversion +126,755 715,653 I
Derivatives
Cox Christopher Nixon Director 2024-02-06 Conversion · Series B Preferred Stock −1,250,000 0 I
Cox Christopher Nixon Director 2024-02-06 Conversion · Series C Preferred Stock −281,917 0 I
Loading xslF345X05/form4-02072024_090202.xml…